Fumarosept

Fumarosept for smokers is available as chewable tablets, packed in boxes of 24 tablets. 

The tablets are formulated without sugar, using isomalt and sucralose as sweeteners, which allows the product to be used even by people with diabetes mellitus, provided there are no other individual contraindications.

Fumarosept is recommended:

• For active smokers, to reduce the frequency of irritative cough;
• For those who have stopped smoking and experience episodes of transient coughing associated with the mucociliary regeneration process;
• For people complaining of a dry mouth caused by exposure to smoke;
• Situations where one wishes to protect the oropharyngeal mucosa and achieve a local cooling effect.

Iceland moss extract (Cetraria islandica) is known for its mucilage content, which has a protective and soothing effect on the mucous membranes, whilst marshmallow extract (Althaea officinalis) contributes its emollient and moisturising properties. 

The recommended method of use is to take 1 or more chewable tablets per day, as required, without exceeding 8 chewable tablets per day.

The tablets should be chewed slowly to allow for optimal dispersion of the active ingredients in the mouth and to prolong the protective effect on the mucous membranes. 

The dosage may be adjusted according to the severity of symptoms, but it is essential to adhere to the maximum daily dose to avoid any digestive reactions associated with excessive consumption of polyols.

Fumarosept is contraindicated in the following cases:

• Hypersensitivity to any of the product’s components;
• Known intolerance to isomalt or other polyols;
• Allergy to the plants present in the formulation (lichens, mallow).

Although the product does not contain sugar, people with metabolic disorders or strict dietary restrictions should consult their doctor before use.

The product can be used both during active smoking and during nicotine withdrawal, when coughing may temporarily become more frequent due to the resumption of mucociliary clearance.

Due to its isomalt content, excessive consumption may have a laxative effect, which is why it is important to adhere to the maximum daily dose.

In general, Fumarosept is well tolerated. However, the following may occur:

• Mild gastrointestinal disturbances (bloating, flatulence, laxative effect) in the event of excessive consumption;
• Rare allergic reactions to the plant-based ingredients;
• Temporary oral discomfort.

The incidence of adverse reactions is low and most symptoms are mild and self-limiting.

No significant drug interactions associated with the use of Fumarosept have been reported.

Due to its predominantly local mechanism of action, the product does not directly interfere with systemic therapies. However, in the event of concomitant administration with other oral products (throat lozenges, oral antiseptics), an interval of at least 30 minutes between doses is recommended to avoid dilution of the local effect.

Overdose is unlikely if the recommended usage is followed.

If an excessive amount is ingested, digestive symptoms such as osmotic diarrhoea, abdominal cramps or gastrointestinal disturbances may occur, due to the polyol content. Treatment is symptomatic and consists of reducing or discontinuing administration.

Fumarosept must be stored in the original packaging, protected from moisture and direct light. It is recommended to store it at temperatures below 25 °C, in a cool, dry place. The product must be kept out of the reach of children and must not be used after the expiry date stated on the packaging.

• WebMD, Lichen pietroso
• PubMed, Althaea officinalis L. and its efficacy in the treatment of cough
• JAPER, Althaea Officinalis in traditional medicine and modern phytotherapy
• PubMed, Icelandic moss lozenges for the prevention or treatment of oral mucosal irritation and dryness of the throat mucosa